Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It hasn’t been easy to be bullish on marijuana stocks in the last few years. After hitting the market with their own bubble in 2018, pot stocks have had a rough go of it. But that looks to be changing. And it could b...
The European Commission has approved GW Pharmaceuticals' (GWPH) Type II variation application for EPIDYOLEX (cannabidiol) as an adjunctive treatment of seizures associated with tuberous sclerosis complex((TSC)), for patients two years of age and older.TSC, a rare genetic condition, ...
– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes epilepsy in up to 85% of patients, and up to 60% of those patients do not respond to standard anti-epileptic medicines 1 ,2 ...
Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) traded at a new 52-week high today of $218.97. Approximately 596,000 shares have changed hands today, as compared to an average 30-day volume of 769,000 shares. In the past 52 weeks, shares of GW Pharmaceuticals Plc have traded between a low...
Real Brands Inc (OTCMKTS:RLBD) is an emerging player on the rejuvenating CBD stock landscape, and one that may deserve attention as a squeeze candidate because the stock has been a target for bears, but one that may be entirely misplaced given the company’s recent strong strides toward...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Economic reports due out next week include the latest updates on existing home sales, new home sales, jobless claims and...
Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) traded today at $219.00, eclipsing its 52-week high. Approximately 596,000 shares have changed hands today, as compared to an average 30-day volume of 769,000 shares. GW Pharmaceuticals PLC is a biopharmaceutical company focused on discoveri...
Palm Beach, FL – April 15, 2021 – 2020 was a prosperous year for medical marijuana. In fact, North America medical marijuana market size alone was over USD 8.1 billion in 2020. The medical cannabis market has made some remarkable continued growth in revenues. Medical marijuana...
Real Brands Inc (OTCMKTS:RLBD) could be perfectly positioned to rise as one of the emerging winners in CBD Boom 2.0. But first, let’s discuss what that means. Remember CBD? Think back to 2017-18. You simply couldn’t avoid those three letters. If you googled “hot stocks...
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies Nabiximols data show efficacy and safety results in patients with spasticity associated with multiple sclerosis ...
News, Short Squeeze, Breakout and More Instantly...
GW Pharmaceuticals Plc Company Name:
GWPH Stock Symbol:
NASDAQ Market:
GW Pharmaceuticals Plc Website:
The key to investing is “Buy low, sell high”. According to that mantra, periods of weakness are the mother’s milk of future gains. When you see them, you know “this is my chance”. It’s the chance to get involved. This is especially true in industries ...
NetworkNewsWire Editorial Coverage : In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain...
Real Brands Inc (OTCMKTS:RLBD) snuck one under the radar late last week, but investors interested in the CBD and Cannabis space should take note. The company filed its Form 10 with the SEC. In this case, it was a voluntary filing because the company does report having over $10 million o...